These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

309 related items for PubMed ID: 6774690

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Live virus vaccines for use in animals.
    Bostock CJ.
    Dev Biol Stand; 1995; 84():41-8. PubMed ID: 7796966
    [No Abstract] [Full Text] [Related]

  • 3. Viral oncogenicity and viral vaccines--general comments.
    Gerber P.
    Natl Cancer Inst Monogr; 1968 Dec; 29():447-8. PubMed ID: 4888932
    [No Abstract] [Full Text] [Related]

  • 4. Immunization against equine viral arteritis using modified live virus propagated in cell cultures of rabbit kidney.
    Doll ER, Bryans JT, Wilson JC, McCollum WH.
    Cornell Vet; 1968 Oct; 48(4):497-524. PubMed ID: 4971878
    [No Abstract] [Full Text] [Related]

  • 5. Technology of production of primary and diploid cell cultures.
    Brackett RG.
    Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
    [No Abstract] [Full Text] [Related]

  • 6. Tissue culture of viruses (author's transl).
    Can J Med Technol; 1974 Jun; 36(3):231 passim. PubMed ID: 4368290
    [No Abstract] [Full Text] [Related]

  • 7. Production of viral vaccines for veterinary use.
    van Gelder P, Makoschey B.
    Berl Munch Tierarztl Wochenschr; 2012 Jun; 125(3-4):103-9. PubMed ID: 22515027
    [Abstract] [Full Text] [Related]

  • 8. Inactivated virus vaccines from chemistry to prophylaxis: merits, risks and challenges.
    Delrue I, Verzele D, Madder A, Nauwynck HJ.
    Expert Rev Vaccines; 2012 Jun; 11(6):695-719. PubMed ID: 22873127
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characteristics of cell culture systems. Viral flora of canine tissues.
    Gillespie JH.
    Natl Cancer Inst Monogr; 1968 Dec; 29():133-9. PubMed ID: 4305426
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG.
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vaccines against dengue virus.
    Woodland DL.
    Viral Immunol; 2015 Mar; 28(2):75. PubMed ID: 25689610
    [No Abstract] [Full Text] [Related]

  • 18. Vaccines produced in heteroploid cell lines--discussion.
    Hull RN.
    Natl Cancer Inst Monogr; 1968 Dec; 29():471-2. PubMed ID: 4976366
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunity of viruses and the effectiveness of vaccines. Mode of virus infections and effectiveness of vaccines].
    Shishido A.
    Nihon Rinsho; 1987 Oct; 45(10):2218-24. PubMed ID: 3448260
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.